Global Retinal Vascular Occlusion Market Size, Status and Forecast 2020-2026

  • receipt Report ID : 29751
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 91
  • list Pharmaceuticals and Healthcare

Retinal Vascular Occlusion (RVO) is the build-up of blood or other fluids in the retina of the eye, which prevents it from properly filtering light caused by the blood clot.

The Americas account for a significant market share owing to high expenditure on the health care, especially, of the U.S. and Canada. Additionally, the greater number of ophthalmology procedures due to greater healthcare penetration in the U.S. and Canada drives the retinal vascular occlusion market. The high concentration of the major hospitals in the developed countries of this region coupled with good reimbursement rates is adding fuel to the market growth. Moreover, the large share of ophthalmology procedures, especially, the retinal vascular occlusion surgery treatment in the returns of hospitals favors the market. The large number of pharmaceutical companies in the U.S. is also a cause for the faster development of retinal vascular occlusion market in the US. The high development of the microsurgery field in developed regions such as the U.S. and Europe is a strong driver of the market.

In 2020, the global Retinal Vascular Occlusion market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2020-2026.

This report focuses on the global Retinal Vascular Occlusion status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Retinal Vascular Occlusion development in United States, Europe and China.

The key players covered in this study

Regeneron Pharmaceuticals, Inc.

Bayer HealthCare Pharmaceuticals LLC.

Novartis AG

Pfizer, Inc.

AstraZeneca PLC.

GlaxoSmithKline PLC.

Johnson & Johnson

Teva pharmaceutical industries

Novo Nordisk

Sanofi

Market segment by Type, the product can be split into

Anti-vascular Endothelial Growth Factor (VEGF)

Corticosteroid

Anticoagulants

Fibrinolytic

Others

Market segment by Application, split into

Hospitals and Clinics

Research and Academics

Others

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Retinal Vascular Occlusion status, future forecast, growth opportunity, key market and key players.

To present the Retinal Vascular Occlusion development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Retinal Vascular Occlusion are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Retinal Vascular Occlusion Market Size Growth Rate by Type (2015-2026)

1.4.2 Anti-vascular Endothelial Growth Factor (VEGF)

1.4.3 Corticosteroid

1.4.4 Anticoagulants

1.4.5 Fibrinolytic

1.4.6 Others

1.5 Market by Application

1.5.1 Global Retinal Vascular Occlusion Market Share by Application (2015-2026)

1.5.2 Hospitals and Clinics

1.5.3 Research and Academics

1.5.4 Others

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Retinal Vascular Occlusion Market Size

2.2 Retinal Vascular Occlusion Growth Trends by Regions

2.2.1 Retinal Vascular Occlusion Market Size by Regions (2015-2026)

2.2.2 Retinal Vascular Occlusion Market Share by Regions (2015-2020)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Retinal Vascular Occlusion Market Size by Manufacturers

3.1.1 Global Retinal Vascular Occlusion Revenue by Manufacturers (2015-2020)

3.1.2 Global Retinal Vascular Occlusion Revenue Market Share by Manufacturers (2015-2020)

3.1.3 Global Retinal Vascular Occlusion Market Concentration Ratio (CR5 and HHI)

3.2 Retinal Vascular Occlusion Key Players Head office and Area Served

3.3 Key Players Retinal Vascular Occlusion Product/Solution/Service

3.4 Date of Enter into Retinal Vascular Occlusion Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Retinal Vascular Occlusion Market Size by Type (2015-2020)

4.2 Global Retinal Vascular Occlusion Market Size by Application (2015-2020)

5 United States

5.1 United States Retinal Vascular Occlusion Market Size (2015-2020)

5.2 Retinal Vascular Occlusion Key Players in United States

5.3 United States Retinal Vascular Occlusion Market Size by Type

5.4 United States Retinal Vascular Occlusion Market Size by Application

6 Europe

6.1 Europe Retinal Vascular Occlusion Market Size (2015-2020)

6.2 Retinal Vascular Occlusion Key Players in Europe

6.3 Europe Retinal Vascular Occlusion Market Size by Type

6.4 Europe Retinal Vascular Occlusion Market Size by Application

7 China

7.1 China Retinal Vascular Occlusion Market Size (2015-2020)

7.2 Retinal Vascular Occlusion Key Players in China

7.3 China Retinal Vascular Occlusion Market Size by Type

7.4 China Retinal Vascular Occlusion Market Size by Application

8 Japan

8.1 Japan Retinal Vascular Occlusion Market Size (2015-2020)

8.2 Retinal Vascular Occlusion Key Players in Japan

8.3 Japan Retinal Vascular Occlusion Market Size by Type

8.4 Japan Retinal Vascular Occlusion Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Retinal Vascular Occlusion Market Size (2015-2020)

9.2 Retinal Vascular Occlusion Key Players in Southeast Asia

9.3 Southeast Asia Retinal Vascular Occlusion Market Size by Type

9.4 Southeast Asia Retinal Vascular Occlusion Market Size by Application

10 India

10.1 India Retinal Vascular Occlusion Market Size (2015-2020)

10.2 Retinal Vascular Occlusion Key Players in India

10.3 India Retinal Vascular Occlusion Market Size by Type

10.4 India Retinal Vascular Occlusion Market Size by Application

11 Central & South America

11.1 Central & South America Retinal Vascular Occlusion Market Size (2015-2020)

11.2 Retinal Vascular Occlusion Key Players in Central & South America

11.3 Central & South America Retinal Vascular Occlusion Market Size by Type

11.4 Central & South America Retinal Vascular Occlusion Market Size by Application

12 International Players Profiles

12.1 Regeneron Pharmaceuticals, Inc.

12.1.1 Regeneron Pharmaceuticals, Inc. Company Details

12.1.2 Company Description and Business Overview

12.1.3 Retinal Vascular Occlusion Introduction

12.1.4 Regeneron Pharmaceuticals, Inc. Revenue in Retinal Vascular Occlusion Business (2015-2020)

12.1.5 Regeneron Pharmaceuticals, Inc. Recent Development

12.2 Bayer HealthCare Pharmaceuticals LLC.

12.2.1 Bayer HealthCare Pharmaceuticals LLC. Company Details

12.2.2 Company Description and Business Overview

12.2.3 Retinal Vascular Occlusion Introduction

12.2.4 Bayer HealthCare Pharmaceuticals LLC. Revenue in Retinal Vascular Occlusion Business (2015-2020)

12.2.5 Bayer HealthCare Pharmaceuticals LLC. Recent Development

12.3 Novartis AG

12.3.1 Novartis AG Company Details

12.3.2 Company Description and Business Overview

12.3.3 Retinal Vascular Occlusion Introduction

12.3.4 Novartis AG Revenue in Retinal Vascular Occlusion Business (2015-2020)

12.3.5 Novartis AG Recent Development

12.4 Pfizer, Inc.

12.4.1 Pfizer, Inc. Company Details

12.4.2 Company Description and Business Overview

12.4.3 Retinal Vascular Occlusion Introduction

12.4.4 Pfizer, Inc. Revenue in Retinal Vascular Occlusion Business (2015-2020)

12.4.5 Pfizer, Inc. Recent Development

12.5 AstraZeneca PLC.

12.5.1 AstraZeneca PLC. Company Details

12.5.2 Company Description and Business Overview

12.5.3 Retinal Vascular Occlusion Introduction

12.5.4 AstraZeneca PLC. Revenue in Retinal Vascular Occlusion Business (2015-2020)

12.5.5 AstraZeneca PLC. Recent Development

12.6 GlaxoSmithKline PLC.

12.6.1 GlaxoSmithKline PLC. Company Details

12.6.2 Company Description and Business Overview

12.6.3 Retinal Vascular Occlusion Introduction

12.6.4 GlaxoSmithKline PLC. Revenue in Retinal Vascular Occlusion Business (2015-2020)

12.6.5 GlaxoSmithKline PLC. Recent Development

12.7 Johnson & Johnson

12.7.1 Johnson & Johnson Company Details

12.7.2 Company Description and Business Overview

12.7.3 Retinal Vascular Occlusion Introduction

12.7.4 Johnson & Johnson Revenue in Retinal Vascular Occlusion Business (2015-2020)

12.7.5 Johnson & Johnson Recent Development

12.8 Teva pharmaceutical industries

12.8.1 Teva pharmaceutical industries Company Details

12.8.2 Company Description and Business Overview

12.8.3 Retinal Vascular Occlusion Introduction

12.8.4 Teva pharmaceutical industries Revenue in Retinal Vascular Occlusion Business (2015-2020)

12.8.5 Teva pharmaceutical industries Recent Development

12.9 Novo Nordisk

12.9.1 Novo Nordisk Company Details

12.9.2 Company Description and Business Overview

12.9.3 Retinal Vascular Occlusion Introduction

12.9.4 Novo Nordisk Revenue in Retinal Vascular Occlusion Business (2015-2020)

12.9.5 Novo Nordisk Recent Development

12.10 Sanofi

12.10.1 Sanofi Company Details

12.10.2 Company Description and Business Overview

12.10.3 Retinal Vascular Occlusion Introduction

12.10.4 Sanofi Revenue in Retinal Vascular Occlusion Business (2015-2020)

12.10.5 Sanofi Recent Development

13 Market Forecast 2020-2026

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2020-2026)

13.10 Market Size Forecast by Application (2020-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Retinal Vascular Occlusion Key Market Segments

Table Key Players Retinal Vascular Occlusion Covered

Table Global Retinal Vascular Occlusion Market Size Gr

Please fill the form below, to recieve the report sample


+1